Source: TOI
Context: Elon Musk’s brain-chip company, Neuralink, received the FDA’s “breakthrough device” designation for its Blindsight implant, designed to restore vision, even for individuals who have lost both eyes and their optic nerve.
- This designation accelerates the development and review process for medical devices that address life-threatening conditions.
- The Blindsight implant is part of Neuralink’s broader mission to restore neural functions.
- Neuralink has already implanted the device in a second patient, enabling them to play video games and design 3D objects.
